The Pathogens Best Paper Award is granted annually to highlight publications of high quality, scientific significance, and extensive influence. The evaluation committee members choose 4 articles of exceptional quality that were published in the journal two years prior and announce the winners online by the end of April 2025.
The Prize:
– One review award: CHF 500 and a chance to publish a paper free of charge in Pathogens in 2025 after peer review;
– Three research article awards:
First prize: CHF 500 and a chance to publish a paper free of charge in Pathogens in 2025 after peer review;
Second prize: CHF 300 and a chance to publish a paper free of charge in Pathogens in 2025 after peer review;
Third prize: CHF 200 and a chance to publish a paper free of charge in Pathogens in 2025 after peer review;
– Each winner will also receive a certificate.
Eligibility and Requirements
– All papers published in Pathogens will be eligible (both regular and Special Issue submissions).
Selection Criteria
– The scientific merit and broad impact of the work;
– The originality of the research objectives and/or the ideas presented;
– The creativity of the study design or uniqueness of the approaches and concepts;
– The clarity of presentation;
– The citations and downloads.
The United Kingdom (UK) and Europe have seen successive outbreaks of H5N1 clade 2.3.4.4b high-pathogenicity avian influenza virus (HPAIV) since 2020 peaking in the autumn/winter periods. During the 2021/22 season, a mass die-off event of Svalbard Bar...
A cross-sectional study was conducted to gain insight into the epidemiology of canine ehrlichiosis and rickettsiosis in northern Portugal. Specific IgG antibodies to Ehrlichia canis were analysed using a commercial enzyme-linked immunosorbent assay (...
Introduction: Human Bocavirus (HBoV) is mainly associated with respiratory tract infections. However, its role as respiratory pathogen is not fully understood for a high co-infection rate in symptomatic patients and a significant HBoV detection rate...
Since its initial description in the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has developed multiple mechanisms for antimicrobial resistance and evading the immune system, including biofilm production. MRSA is now a widespread pathog...
Moriya Tsuji
Deborah Anderson
Roberto PAGANELLI
Steven Zeichner
Melinda Brindley
Tommy Alain
Edward Breitschwerdt
Nick Heng
Richard Dix
Ian Hampson
Dana G. Mordue
Ramesh Vemulapalli
Xin Li
Makoto Ozawa
Xuguang Li
Carstem Münk
Laurel L. Lenz
